Results 41 to 50 of about 786,314 (373)

Methods for Detecting and Measuring Adverse Hospital Events [PDF]

Iranian Journal of Public Health, 2005
Introduction: An adverse event is defined as an unexpected event such as a patient fall, a drug reaction or an infection, which leads to patient injury and is caused by healthcare management rather than patient own diseases.
A Baba-Akbari Sari, TA Sheldon
doaj   +2 more sources

Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study

British medical journal, 2022
Objective To characterize potential drug safety signals identified from the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS), from 2008 to 2019, to determine how often these signals resulted in regulatory action by the FDA and
Meera M Dhodapkar, Xiaoting Shi, Reshma Ramachandran, Evan Chen, J. Wallach, Joseph S. Ross   +5 more
semanticscholar   +1 more source

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System [PDF]

Drugs - Real World Outcomes, 2019
Serious cardiovascular adverse events (SCAEs) associated with intravenous sedatives remain poorly characterized.The objective of this study was to compare SCAE incidence, types, and mortality between intravenous benzodiazepines (i.e., diazepam, lorazepam, and midazolam), dexmedetomidine, and propofol in the USA over 8 years regardless of the clinical ...
Jonathan Weinstock, Mo Dimbil, Nick O'Donnell, Christopher Madias, Keith B. Hoffman, Matthew S. Duprey, Nada S. Al-Qadheeb, John W. Devlin, John W. Devlin   +8 more
openaire   +3 more sources

Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter [PDF]

, 2014
Background: Traditional adverse event (AE) reporting systems have been slow in adapting to online AE reporting from patients, relying instead on gatekeepers, such as clinicians and drug safety groups, to verify each potential event.
Bao, Wenjie, Brownstein, John S., Dasgupta, Nabarun, Filice, Ross, Freifeld, Clark C., Kass-Hout, Taha, Menone, Christopher M.   +6 more
core   +3 more sources

Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

Drug Safety, 2022
As chimeric antigen receptor T-cell therapies are becoming increasingly available in the armamentarium of the hematologist, there is an emerging need to monitor post-marketing safety.
M. Fusaroli, Valentina Isgró, P. Cutroneo, C. Ferrajolo, Valentina Cirillo, F. del Bufalo, E. Raschi, E. Poluzzi, G. Trifirò   +8 more
semanticscholar   +1 more source

Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database

Frontiers in Pharmacology, 2022
Aims: We aimed to estimate the risk of drug-induced liver injury (DILI) from various antifungal treatments with azoles and echinocandins causing in real-world practice. Methods: We performed disproportionality and Bayesian analyses based on data from the
Zhi-xuan Zhou, Xue-dong Yin, Yu Zhang, Qi-hui Shao, X. Mao, Wen-juan Hu, Yunfang Shen, Bin Zhao, Zhi-ling Li   +8 more
semanticscholar   +1 more source

Adverse drug event reporting systems: a systematic review [PDF]

British Journal of Clinical Pharmacology, 2016
AimAdverse drug events (ADEs) are harmful and unintended consequences of medications. Their reporting is essential for drug safety monitoring and research, but it has not been standardized internationally. Our aim was to synthesize information about the type and variety of data collected within ADE reporting systems.MethodsWe developed a systematic ...
David Peddie, David Peddie, Maeve E. Wickham, Maeve E. Wickham, Ellen Balka, Ellen Balka, Mary M. Doyle-Waters, Katherin Badke, Katherin Badke, Chantelle Bailey, Chantelle Bailey, Corinne M. Hohl, Corinne M. Hohl, Serena S Small, Serena S Small   +14 more
openaire   +2 more sources

Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System

SAGE Open Medicine, 2019
Objectives: Paclitaxel is a highly effective antitumor agent with notable adverse events, including hypersensitivity reactions, peripheral neuropathy, arthralgia, myalgias, and neutropenia.
Misa Naganuma, Kohei Tahara, Shiori Hasegawa, Akiho Fukuda, Sayaka Sasaoka, Haruna Hatahira, Yumi Motooka, Satoshi Nakao, Ririka Mukai, Kouseki Hirade, Tomoaki Yoshimura, Takeshi Kato, Hirofumi Takeuchi, Mitsuhiro Nakamura   +13 more
doaj   +1 more source

Wine Quality Assessment under the Eindhoven Classification Method [PDF]

, 2019
The identification, classification and recording of events leading to deterioration of wine quality is essential for developing appropriate strategies to avoid them.
Aranha, Inês, Chaves, Humberto, Crespo, Ana, Fernandes, Ana, Figueiredo, Margarida, Neves, José, Pereira, Ana, Ribeiro, Jorge, Vicente, Henrique   +8 more
core   +2 more sources

Contributory factors in surgical incidents as delineated by a confidential reporting system [PDF]

, 2018
Background Confidential reporting systems play a key role in capturing information about adverse surgical events. However, the value of these systems is limited if the reports that are generated are not subjected to systematic analysis.
Kapur, N, Lawton, R, Mushtaq, F, O’Driscoll, C, Smith, FCT, Wilkins, D   +5 more
core   +1 more source